adminPfizer Inc. (PFE) Q4 2025 Earnings Call February 3, 2026 10:00 AM EST
Company Participants
Francesca DeMartino – Chief Investor Relations Officer
Albert Bourla – Chairman of the Board & CEO
Chris Boshoff – Chief Scientific Officer and President of Research & Development
David Denton – Executive VP & CFO
Aamir Malik – Executive VP & Chief U.S. Commercial Officer
Alexandre de Germay – Executive VP & Chief International Commercial Officer
Conference Call Participants
Christopher Schott – JPMorgan Chase & Co, Research Division
Vamil Divan – Guggenheim Securities, LLC, Research Division
Steve Scala – TD Cowen, Research Division
Geoffrey Meacham – Citigroup Inc., Research Division
Terence Flynn – Morgan Stanley, Research Division
Akash Tewari – Jefferies LLC, Research Division
Asad Haider – Goldman Sachs Group, Inc., Research Division
Courtney Breen – Bernstein Institutional Services LLC, Research Division
Umer Raffat – Evercore ISI Institutional Equities, Research Division
Jason Gerberry – BofA Securities, Research Division
Michael Yee
Alexandria Hammond – Wolfe Research, LLC
Mohit Bansal – Wells Fargo Securities, LLC, Research Division
Evan Seigerman – BMO Capital Markets Equity Research
David Risinger – Leerink Partners LLC, Research Division
Louise Chen – Scotiabank Global Banking and Markets, Research Division
Presentation
Operator
Good day, everyone, and welcome to Pfizer’s Fourth Quarter 2025 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma’am.
Francesca DeMartino
Chief Investor Relations Officer
Good morning, and welcome to Pfizer’s earnings call. I’m Francesca DeMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us. This call is being made available via audio webcast at pfizer.com. Earlier this morning, we released our results for the fourth quarter and full year 2025 via a press release that is available on our website at pfizer.com.
I’m joined today by Dr. Albert Bourla, our
Read the full article here
